Clinical trial
Impact of Fingolimod Adherence on Outcomes
NCT05141669 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Fingolimod Adherence on Outcomes
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 18, 2020
- Completion date
- November 20, 2020
- Enrollment
- 694 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.